MASLD prevalence was significantly higher with elevated leptin (44% vs. 30%, p < 0.001), while quantitative steatosis measures confirmed this relationship with higher CAP values (270 vs. 241 dB/m, p < 0.001) and fatty liver index scores. This evidence concerns the gene LEP and Hepatic steatosis.